FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W58041913> ?p ?o ?g. }

• W58041913 endingPage "68" @default.
• W58041913 startingPage "49" @default.
• W58041913 abstract "The identification of some of the adaptive immune responses to infection with equine viruses has been the first step toward rational immunoprophylactic design. Sufficient knowledge of infection-induced immunity and informed estimates of the requirements for long-term immunity for EIV have now been obtained. Thus, the future for inactivated EIV vaccines is promising now that new adjuvants have been applied to induce cellular immunity and safe methods have been designed to stimulate virus-neutralizing (VN) antibody at mucosal surfaces. Adenoviruses induce circulating VN antibody, the presence of which appears to correlate with protection from reinfection. Therefore, the potential of vaccines to induce VN antibody and protect from challenge is an important next step with this virus. With persistent viruses such as EHV-1, antibody-mediated protection from infection can be achieved only at the site of initial infection, that is, the nasopharynx and upper respiratory tract. Systemic dissemination is very rapid and consequently VN antibody is unlikely to play a major role in prevention of disease once the initial infection event has occurred. Cellular immune responses, particularly CTLs, play a dominant role in protection and recovery and are important in immune surveillance and determination of the outcome of reactivation of latent virus. Therefore, the key to future EHV-1 vaccine design is to focus on stimulation of CTL responses, and this requires the successful presentation of vaccine-derived antigenic peptides to MHC class I molecules that are recognized by specific receptors on CTL. There is some evidence that stimulation of EHV-1-specific CTL precursors may correlate with immunity to this virus. By analogy with gamma herpesviruses in humans, CTL precursor frequency may also function as an immune correlate for EHV-2. Although EAV infection induces strong immunity in females and geldings, persistent infection of the genital tract is an important route of dissemination from stallions. Although inactivated vaccines induce strong immunity (which depends upon VN activity of serum antibody) to first infection, the immunologic control of persistent infection is currently poorly understood; however, analogy with other persistent viruses suggests that CTLs are also likely to play an important role in the control of persistent EAV infections." @default.
• W58041913 created "2016-06-24" @default.
• W58041913 creator A5008568086 @default.
• W58041913 creator A5058359632 @default.
• W58041913 date "2000-04-01" @default.
• W58041913 modified "2023-10-16" @default.
• W58041913 title "Equine Immunity to Viruses" @default.
• W58041913 cites W1517021800 @default.
• W58041913 cites W1578624224 @default.
• W58041913 cites W1976601347 @default.
• W58041913 cites W1977945339 @default.
• W58041913 cites W1988363032 @default.
• W58041913 cites W1991464867 @default.
• W58041913 cites W1998445209 @default.
• W58041913 cites W2018155407 @default.
• W58041913 cites W2020750867 @default.
• W58041913 cites W2024212171 @default.
• W58041913 cites W2031089520 @default.
• W58041913 cites W2031193236 @default.
• W58041913 cites W2049624095 @default.
• W58041913 cites W2053148124 @default.
• W58041913 cites W2063238535 @default.
• W58041913 cites W2069417575 @default.
• W58041913 cites W2070598138 @default.
• W58041913 cites W2079654991 @default.
• W58041913 cites W2084094785 @default.
• W58041913 cites W2086057672 @default.
• W58041913 cites W2086996704 @default.
• W58041913 cites W2087296395 @default.
• W58041913 cites W2092404785 @default.
• W58041913 cites W2098301202 @default.
• W58041913 cites W2105093420 @default.
• W58041913 cites W2108393982 @default.
• W58041913 cites W2116700129 @default.
• W58041913 cites W2145661290 @default.
• W58041913 cites W2163448246 @default.
• W58041913 cites W2177327503 @default.
• W58041913 cites W2337732271 @default.
• W58041913 cites W967850398 @default.
• W58041913 doi "https://doi.org/10.1016/s0749-0739(17)30118-9" @default.
• W58041913 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10752138" @default.
• W58041913 hasPublicationYear "2000" @default.
• W58041913 type Work @default.
• W58041913 sameAs 58041913 @default.
• W58041913 citedByCount "24" @default.
• W58041913 countsByYear W580419132014 @default.
• W58041913 countsByYear W580419132015 @default.
• W58041913 countsByYear W580419132016 @default.
• W58041913 countsByYear W580419132018 @default.
• W58041913 countsByYear W580419132022 @default.
• W58041913 crossrefType "journal-article" @default.
• W58041913 hasAuthorship W58041913A5008568086 @default.
• W58041913 hasAuthorship W58041913A5058359632 @default.
• W58041913 hasConcept C147483822 @default.
• W58041913 hasConcept C147969180 @default.
• W58041913 hasConcept C159047783 @default.
• W58041913 hasConcept C159654299 @default.
• W58041913 hasConcept C167672396 @default.
• W58041913 hasConcept C193419808 @default.
• W58041913 hasConcept C203014093 @default.
• W58041913 hasConcept C2522874641 @default.
• W58041913 hasConcept C2779341262 @default.
• W58041913 hasConcept C86803240 @default.
• W58041913 hasConcept C8891405 @default.
• W58041913 hasConceptScore W58041913C147483822 @default.
• W58041913 hasConceptScore W58041913C147969180 @default.
• W58041913 hasConceptScore W58041913C159047783 @default.
• W58041913 hasConceptScore W58041913C159654299 @default.
• W58041913 hasConceptScore W58041913C167672396 @default.
• W58041913 hasConceptScore W58041913C193419808 @default.
• W58041913 hasConceptScore W58041913C203014093 @default.
• W58041913 hasConceptScore W58041913C2522874641 @default.
• W58041913 hasConceptScore W58041913C2779341262 @default.
• W58041913 hasConceptScore W58041913C86803240 @default.
• W58041913 hasConceptScore W58041913C8891405 @default.
• W58041913 hasIssue "1" @default.
• W58041913 hasLocation W580419131 @default.
• W58041913 hasLocation W580419132 @default.
• W58041913 hasOpenAccess W58041913 @default.
• W58041913 hasPrimaryLocation W580419131 @default.
• W58041913 hasRelatedWork W1484759019 @default.
• W58041913 hasRelatedWork W1979511395 @default.
• W58041913 hasRelatedWork W2052483994 @default.
• W58041913 hasRelatedWork W2054816609 @default.
• W58041913 hasRelatedWork W2063162447 @default.
• W58041913 hasRelatedWork W2139983200 @default.
• W58041913 hasRelatedWork W2220102944 @default.
• W58041913 hasRelatedWork W4307359803 @default.
• W58041913 hasRelatedWork W573847062 @default.
• W58041913 hasRelatedWork W62304571 @default.
• W58041913 hasVolume "16" @default.
• W58041913 isParatext "false" @default.
• W58041913 isRetracted "false" @default.
• W58041913 magId "58041913" @default.
• W58041913 workType "article" @default.